ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02717962
Recruitment Status : Recruiting
First Posted : March 24, 2016
Last Update Posted : January 18, 2018
Sponsor:
Information provided by (Responsible Party):
DelMar Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2020
  Estimated Study Completion Date : June 2021